Crossmark

The lung environment controls alveolar macrophage metabolism and responsiveness in type 2 inflammation

Crossref DOI link: https://doi.org/10.1038/s41590-019-0352-y

Published Online: 2019-04-01

Published Print: 2019-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Svedberg, Freya R.

Brown, Sheila L.

Krauss, Maria Z.

Campbell, Laura

Sharpe, Catherine

Clausen, Maryam

Howell, Gareth J.

Clark, Howard https://orcid.org/0000-0001-7354-2028
Madsen, Jens

Evans, Christopher M.

Sutherland, Tara E. https://orcid.org/0000-0001-9334-8206
Ivens, Alasdair C.

Thornton, David J. https://orcid.org/0000-0001-7148-1970
Grencis, Richard K.

Hussell, Tracy

Cunoosamy, Danen M.

Cook, Peter C. https://orcid.org/0000-0002-5208-4985
MacDonald, Andrew S. https://orcid.org/0000-0002-5356-1149
License Information

Text and Data Mining valid from 2019-04-01
More Information

Article History

Received: 12 April 2018

Accepted: 14 February 2019

First Online: 1 April 2019

Competing interests

: The Manchester Collaborative Centre for Inflammation Research is a joint venture between the University of Manchester, AstraZeneca and GSK. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.